IFNAR1 and infection: The correlation between human case studies and our data suggests that the IFNAR-/- mouse SFTSV infection model may be useful for evaluating antiviral treatments combined with adjunctive therapy to limit vascular leak directly or through modulation of the intensity and duration of the proinflammatory cytokine response.